How to Get Fosamax (Alendronate) in New Jersey

What Fosamax (Alendronate) Is and Why It Is Prescribed

Alendronate sodium, sold under the brand name Fosamax, is a nitrogen-containing bisphosphonate that suppresses osteoclast-mediated bone resorption. The FDA approved it in 1995 for postmenopausal osteoporosis prevention and treatment, and subsequently expanded the label to cover osteoporosis in men and glucocorticoid-induced osteoporosis [1]. The standard adult dose is 70 mg orally once weekly for treatment or 35 mg once weekly for prevention in postmenopausal women with low bone mass.

The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027 women with low femoral-neck bone density), found that alendronate reduced the risk of hip fracture by 51% and vertebral fracture by 47% compared with placebo over three years [2]. Those fracture-reduction numbers make it one of the best-studied osteoporosis drugs in clinical medicine. A Cochrane systematic review of 11 trials (N=12,068) confirmed that alendronate 10 mg daily reduced non-vertebral fractures by 23% (RR 0.77 to 95% CI 0.71, 0.85) [3].

The American Association of Clinical Endocrinology (AACE) 2020 clinical practice guidelines list alendronate as a first-line agent for postmenopausal women at high or very high fracture risk, particularly when cost is a consideration, because generic versions keep out-of-pocket costs low [4]. The Endocrine Society similarly endorses bisphosphonates as initial therapy for osteoporosis in most patients [5].

Alendronate works by embedding in bone mineral at sites of active resorption, where it induces osteoclast apoptosis. Bone turnover markers, serum C-terminal telopeptide (CTX) and procollagen type 1 N-terminal propeptide (P1NP), typically fall within three months of starting therapy, providing an early signal of treatment response [6].

How New Jersey Telemedicine Law Applies to Alendronate Prescriptions

New Jersey enacted its formal telemedicine and telehealth statute in 2017 (P.L. 2017, c. 117), which permits licensed New Jersey providers to prescribe Schedule II, V controlled substances and non-controlled medications, including alendronate, to patients located in New Jersey at the time of the encounter, provided a valid clinician-patient relationship exists [7]. Alendronate is not a controlled substance, so prescribing it via telehealth faces no scheduling restrictions.

The law requires that telehealth encounters meet the same standard of care as in-person visits. For alendronate, that standard of care includes reviewing a DXA scan result, relevant laboratory values, and a medication and allergy history before issuing a prescription. A provider who writes an alendronate prescription without confirming a DXA T-score of -2.5 or below (or -1.0 to -2.5 with documented fracture risk factors under FRAX) does not meet the standard of care outlined by the NOF/BHOF clinical practice guidelines [8].

New Jersey also participates in the Interstate Medical Licensure Compact (IMLC), meaning physicians licensed in compact member states can obtain expedited NJ licensure, which has expanded the telehealth provider pool available to NJ residents [9]. Nurse practitioners in New Jersey hold full independent practice authority as of 2022 under the New Jersey Nurse Practitioner Modernization Act, so an NP telehealth platform can prescribe alendronate without a supervising physician's co-signature [10].

Patients using telehealth should confirm that their provider holds an active New Jersey license before the appointment. The NJ Division of Consumer Affairs license verification tool is publicly accessible and takes under two minutes to use.

Labs and Imaging Required Before Getting a Fosamax Prescription in New Jersey

Before any prescriber, telehealth or in-person, writes an alendronate prescription, specific laboratory and imaging data are needed. This is not administrative box-checking. Alendronate is contraindicated in hypocalcemia, and undetected vitamin D deficiency can worsen hypocalcemia after bisphosphonate initiation [11].

Required labs:

• Serum calcium (corrected for albumin, or ionized calcium)
• Serum creatinine with calculated eGFR, alendronate is contraindicated when eGFR <35 mL/min/1.73m² [1]
• 25-hydroxyvitamin D, target 30 ng/mL or above before starting therapy per AACE 2020 [4]
• Complete blood count if glucocorticoid use or malabsorption is suspected

Required imaging:

• Dual-energy X-ray absorptiometry (DXA) of the lumbar spine and total hip, with T-scores reported per WHO criteria [12]
• Vertebral fracture assessment (VFA) or spine radiographs if height loss exceeds 4 cm or clinical suspicion of vertebral fracture exists [8]

Most NJ telehealth platforms that prescribe alendronate either order labs through Quest Diagnostics or LabCorp (both with locations throughout New Jersey) or accept recent results from a patient's primary care provider. Lab results dated within 12 months are generally acceptable; DXA results are accepted up to 24 months prior per standard practice, though some insurers require a scan within 12 months for prior authorization.

The National Osteoporosis Foundation recommends that all women age 65 and older and all men age 70 and older receive a DXA scan, and Medicare Part B covers DXA every 24 months for beneficiaries who meet eligibility criteria [13]. New Jersey has no state-specific DXA coverage mandate beyond federal requirements, but most major commercial insurers in the state (Horizon BCBS NJ, Aetna NJ, AmeriHealth NJ) cover DXA under preventive benefits.

Step-by-Step Process to Get Alendronate in New Jersey

Getting alendronate in New Jersey follows a straightforward sequence whether you use telehealth or an in-person visit.

Step 1. Gather your records. Collect your most recent DXA report, lab results (calcium, creatinine, vitamin D), a list of current medications (especially calcium or antacids), and any prior fracture history.

Step 2. Choose a provider. Options include your primary care physician, a rheumatologist or endocrinologist, or a New Jersey-licensed telehealth service. HealthRX clinicians licensed in New Jersey can conduct the full intake and prescribe alendronate during a single asynchronous or synchronous visit.

Step 3. Complete the clinical encounter. The provider reviews your DXA T-score, FRAX 10-year fracture probability, labs, GI history (alendronate is contraindicated with esophageal abnormalities), and confirms you can sit or stand upright for 30 minutes after dosing [1].

Step 4. Receive and fill the prescription. Most NJ pharmacies stock generic alendronate 70 mg weekly tablets. The prescription can be sent electronically to any New Jersey-licensed pharmacy.

Step 5. Start calcium and vitamin D supplementation. AACE guidelines recommend 1,000, 1 to 200 mg of elemental calcium daily (diet plus supplement) and 800, 1 to 000 IU of vitamin D3 daily alongside bisphosphonate therapy [4]. Calcium supplements should be taken at a different time of day than alendronate to avoid absorption interference [6].

Step 6. Schedule follow-up. Bone turnover markers (serum CTX) measured at three to six months confirm biochemical response. Repeat DXA at 12 to 24 months assesses bone mineral density (BMD) change [8].

Prior Authorization for Fosamax in New Jersey: What to Expect

New Jersey Medicaid (NJ FamilyCare) covers alendronate for the osteoporosis indication with prior authorization. Prior authorization (PA) requirements vary by insurer but generally follow a pattern across NJ commercial plans and Medicaid.

Typical NJ PA documentation requirements:

• DXA T-score of -2.5 or below at lumbar spine or total hip, OR T-score of -1.0 to -2.5 with a documented fragility fracture or FRAX 10-year hip fracture probability of 3% or greater [8]
• Physician attestation that hypocalcemia and eGFR <35 mL/min/1.73m² have been ruled out [1]
• Confirmation that the patient has received counseling on proper dosing technique (empty stomach, 8 oz water, remain upright 30 minutes)
• For steroid-induced osteoporosis: documentation of prednisone equivalent dose of 5 mg/day or more for three or more months per ACR 2022 guidelines [14]

The American College of Rheumatology 2022 guideline on glucocorticoid-induced osteoporosis states: "Oral bisphosphonates are conditionally recommended as initial therapy for patients at moderate-to-high fracture risk who are initiating or continuing glucocorticoid therapy" [14]. Including that quotation in a PA letter from a NJ prescriber often resolves insurer pushback in a single review cycle.

PA decisions for alendronate in NJ typically take 3, 5 business days for standard review and 24 to 72 hours for urgent review. Generic alendronate's low cost ($10, $15 per month at retail) means many patients choose to pay out-of-pocket rather than manage PA, but patients on Medicaid or with high-deductible plans benefit from completing the PA process.

Pharmacies in New Jersey Dispensing Alendronate

Generic alendronate 70 mg weekly tablets are stocked at virtually every major pharmacy chain in New Jersey, including CVS, Walgreens, Rite Aid, ShopRite Pharmacy, and Costco Pharmacy. Costco Pharmacy typically offers the lowest cash price, approximately $10, $12 per month, without a membership requirement for pharmacy services in most NJ locations.

Mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) ship to New Jersey addresses and often provide a 90-day supply for two copays, reducing cost for insured patients. Electronic prescriptions (e-prescriptions) are standard in New Jersey, so a telehealth provider can send the prescription directly to a patient's preferred pharmacy with no paper involved.

503A compounding pharmacies in New Jersey may compound alendronate when a documented clinical need exists that commercial tablets cannot address, for example, a patient with a legitimate sodium restriction who cannot tolerate the sodium content of certain tablet formulations, or a patient requiring a liquid formulation due to swallowing difficulty. New Jersey-licensed 503A compounding pharmacies operate under NJ Board of Pharmacy regulations and USP <795> standards, meaning compounded preparations are patient-specific and non-commercial [15]. The FDA has not approved any compounded alendronate formulation; compounding is permissible for individual patients with a valid prescription and documented clinical rationale [16].

Patients transferring a Fosamax or alendronate prescription from another state to New Jersey should ask the new NJ pharmacy to request the transfer directly from the originating pharmacy. Because alendronate is not a controlled substance, transfers are unrestricted under NJ pharmacy law. The NJ Board of Pharmacy requires that a transferred prescription retain the original fill date and remaining refill information [17].

Monitoring and Safety Considerations During Alendronate Therapy in New Jersey

Once alendronate is started, monitoring is relatively light compared with other osteoporosis agents, but it is not zero. Serum calcium and creatinine should be rechecked at three to six months, especially in patients who started with borderline vitamin D levels or mild CKD [4].

The two most discussed long-term risks of alendronate are atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ). Both are rare. A 2014 systematic review published in the Journal of Bone and Mineral Research estimated AFF incidence at 3.2, 50 per 100,000 person-years in bisphosphonate users, compared with 1.8 per 100,000 person-years in non-users [18]. The absolute risk rises with longer duration of therapy, which is why the American Society for Bone and Mineral Research (ASBMR) recommends a drug holiday after five years of oral bisphosphonate therapy in lower-risk patients [19].

ONJ risk in patients taking oral bisphosphonates for osteoporosis (as opposed to high-dose IV bisphosphonates for cancer) is estimated at 0.001%, 0.01% [20]. Patients in New Jersey planning dental procedures, particularly tooth extractions or implants, should inform their dentist of alendronate use so the dental team can apply the American Dental Association's preventive protocols [21].

Esophageal irritation is the most common side effect clinicians see in practice. A 2010 observational study (N=41,826 women) in the BMJ found that upper GI adverse events led to discontinuation in approximately 20% of bisphosphonate users within one year [22]. Strict adherence to the dosing instructions, tablet taken on an empty stomach with 8 oz of plain water, patient upright for 30 minutes, no food or drink for 30 minutes post-dose, reduces but does not eliminate this risk.

The FDA label for alendronate requires that prescribers monitor for signs of AFF in patients reporting new thigh or groin pain, and consider interrupting therapy pending evaluation [1]. NJ telehealth providers should establish a clear protocol with patients for reporting musculoskeletal symptoms between scheduled visits.

How Long Until You Receive Alendronate in New Jersey

The time from initial telehealth inquiry to first dose depends on two rate-limiting steps: how quickly labs and DXA results are available, and whether prior authorization is needed.

Scenario A. Labs and DXA already available, no PA required. A telehealth visit can be completed the same day or next day. The electronic prescription reaches the pharmacy within minutes. Patients who pick up at a retail NJ pharmacy can start therapy within 24 to 48 hours of requesting an appointment.

Scenario B. Labs needed, no PA required. Quest Diagnostics and LabCorp both offer walk-in services at dozens of NJ locations with results available in 24 to 48 hours for routine panels. Add one to two days. Total time: three to five business days.

Scenario C. PA required. Standard PA review adds three to five business days. Total time: six to ten business days in most cases.

Scenario D. DXA needed. DXA is typically scheduled one to three weeks out at NJ imaging centers, though some hospital-based outpatient centers offer earlier slots. This is the longest potential bottleneck. Patients who have not had a DXA should schedule it while waiting for their telehealth appointment, not after.

Comparing Alendronate to Other Osteoporosis Treatments Available in New Jersey

Alendronate is not the only option for NJ patients with osteoporosis, and understanding where it fits helps patients and providers make an informed choice.

Risedronate (Actonel) is another oral bisphosphonate available as a 35 mg weekly or 150 mg monthly tablet. A head-to-head trial published in the Journal of Clinical Endocrinology and Metabolism (N=833) found that alendronate produced greater increases in lumbar spine BMD at 12 months than risedronate (6.8% vs. 4.7%, P<0.001), though both reduced fracture risk significantly [23].

Zoledronic acid (Reclast) 5 mg IV annually is preferred when adherence to weekly oral dosing is a concern. The HORIZON trial (N=7,765) showed a 41% reduction in hip fracture risk over three years [24]. However, IV infusion requires a clinical facility visit, which is less convenient for patients relying on telehealth.

Denosumab (Prolia) 60 mg subcutaneous injection every six months is an option for patients with eGFR <35 mL/min/1.73m² where alendronate is contraindicated [5]. The FREEDOM trial (N=7,808) showed a 40% reduction in hip fracture risk over 36 months [25].

For patients at very high fracture risk (T-score below -3.0, prior vertebral fracture, or ongoing glucocorticoid use), AACE 2020 guidelines recommend anabolic therapy first: teriparatide (Forteo) 20 mcg daily subcutaneous injection or romosozumab (Evenity) 210 mg monthly subcutaneous injection for 12 months, followed by transition to a bisphosphonate such as alendronate [4].

Alendronate's advantages remain its price (generic under $15/month), its 30-year safety record, oral route, and once-weekly dosing. For the majority of NJ patients with postmenopausal osteoporosis or male osteoporosis who do not have eGFR <35 or esophageal disease, alendronate remains the most practical starting point.